Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | +5.44% | +4.49% | -19.21% |
Sales 2024 * | 104M 142M | Sales 2025 * | 119M 162M | Capitalization | 183M 249M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 11M 15.01M | EV / Sales 2024 * | 1.76 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
-349
x | P/E ratio 2025 * |
17
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.06% |
Latest transcript on Alimera Sciences, Inc.
1 day | +5.44% | ||
1 week | +4.49% | ||
Current month | -10.51% | ||
1 month | -10.51% | ||
3 months | -10.97% | ||
6 months | +10.44% | ||
Current year | -19.21% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.49 | +5.44% | 17,332 |
24-04-25 | 3.31 | -8.82% | 25,225 |
24-04-24 | 3.63 | +1.11% | 7,722 |
24-04-23 | 3.59 | +1.41% | 16,176 |
24-04-22 | 3.54 | +5.99% | 25,959 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.21% | 183M | |
-4.64% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ALIM Stock